Filing Details
- Accession Number:
- 0001127602-13-026471
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-03 17:15:21
- Reporting Period:
- 2013-08-29
- Filing Date:
- 2013-09-03
- Accepted Time:
- 2013-09-03 17:15:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1014739 | Bioscrip Inc. | BIOS | Retail-Drug Stores And Proprietary Stores (5912) | 050489664 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1546304 | Daniel Colucci | C/O Bioscrip, Inc. 100 Clearbrook Road Elmsford NY 10523 | Vice President, Pbm Services | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 Par Value | Acquisiton | 2013-08-29 | 9,758 | $2.73 | 12,338 | No | 4 | M | Direct | |
| Common Stock, $.0001 Par Value | Disposition | 2013-08-29 | 9,758 | $12.47 | 2,580 | No | 4 | S | Direct | |
| Common Stock, $.0001 Par Value | Acquisiton | 2013-08-30 | 8,742 | $2.73 | 11,322 | No | 4 | M | Direct | |
| Common Stock, $.0001 Par Value | Disposition | 2013-08-30 | 8,742 | $12.32 | 2,580 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 Par Value | Employee Stock Option | Disposition | 2013-08-29 | 9,758 | $0.00 | 9,758 | $2.73 |
| Common Stock, $.0001 Par Value | Employee Stock Option | Disposition | 2013-08-30 | 8,742 | $0.00 | 8,742 | $2.73 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,742 | 2010-04-28 | 2019-04-28 | No | 4 | M | Direct |
| 0 | 2010-04-28 | 2019-04-28 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 Par Value | Employee Stock Option | $6.65 | 2011-06-16 | 2020-06-16 | 5,500 | 5,500 | Direct |
| Common Stock, $.0001 Par Value | Employee Stock Option | $4.42 | 2012-04-26 | 2021-04-26 | 20,000 | 20,000 | Direct |
| Common Stock, Par Value $0.0001 Per Share | Stock Option (Right to Buy) | $11.04 | 2014-03-08 | 2023-03-08 | 50,000 | 50,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2020-06-16 | 5,500 | 5,500 | Direct |
| 2021-04-26 | 20,000 | 20,000 | Direct |
| 2023-03-08 | 50,000 | 50,000 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.45 to $12.53, inclusive. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.30 to $12.36, inclusive. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Fully Vested.
- Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
Billionaire Hedge Funds
